µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2033³â)
Veterinary Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå¿¡ °üÇÑ ±¤¹üÀ§ÇÑ Á¶»ç ¸®Æ÷Æ®¸¦ ÃâÆÇÇϸç, ÃËÁø·Â, »õ·Î¿î µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇÐÀÇ Ã¶ÀúÇÑ ºÐ¼®À» Á¦°øÇß½À´Ï´Ù. º» ¸®Æ÷Æ®´Â ½ÃÀå ±¸µµ¸¦ Á¾ÇÕÀûÀ¸·Î ÀÌÇØÇϰí, ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤À» ½ÃÇàÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð(2024³â) : 2¾ï 1,470¸¸ ´Þ·¯
½ÃÀå ¿¹Ãø ±Ý¾×(2033³â) : 4¾ï 3,770¸¸ ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2033³â) : 8.2%
µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀå - Á¶»ç ¹üÀ§ :
µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀº µ¿¹°ÀÇ Áúº´À» Á¤È®ÇÏ°Ô °ËÃâÇÏ°í ºÐ¼®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÏ·ÃÀÇ Ã·´Ü Áø´Ü ±â¼úÀ» Æ÷°ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú¿¡´Â ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR), Â÷¼¼´ë ¿°±â¼¿ºÐ¼®(NGS) ¹× ´Ù¾çÇÑ ¼öÀÇÇÐ ÁúȯÀÇ Áø´Ü¿¡ ³ôÀº ¹Î°¨µµ¿Í ƯÀ̼ºÀ» Á¦°øÇÏ´Â ±âŸ ºÐÀÚ ¹æ¹ýÀÌ Æ÷ÇԵ˴ϴÙ. ºÐÀÚÁø´Ü¹ýÀº ¹Ý·Áµ¿¹°°ú °¡ÃàÀÇ º´¿øÃ¼, À¯ÀüÀû Áúº´ ¹× ±âŸ °Ç° ¹®Á¦¸¦ ½Äº°Çϰí Áúº´ °ü¸® ¹× Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ºÐÀÚ»ý¹°ÇÐÀÇ ¹ßÀü, Àμö°øÅëÀü¿°º´ Áõ°¡, ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀåÀÇ ÃËÁø¿äÀÎ:
¼¼°è µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀº µ¿¹°ÀÇ °¨¿°¼º Áúȯ ¹ßº´·ü Áõ°¡, ¹Ý·Áµ¿¹° »çÀ° Áõ°¡, µ¿¹° °Ç°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ºÐÀÚÁø´ÜÀº Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ °á°ú¸¦ Á¦°øÇÏ¿© È¿°úÀûÀÎ Áúº´ °ü¸® ¹× ¿¹¹æ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¶ÇÇÑ µ¿¹° ÀÇ·á ÀÎÇÁ¶óÀÇ È®Ãæ°ú ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î Áø´Ü ±â±âÀÇ °³¹ß µî Áø´Ü ±â¼úÀÇ ¹ßÀüµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºÐÀÚÁø´Ü°ú ¿ø°ÝÀÇ·á ¹× µðÁöÅÐ °Ç° ¼Ö·ç¼ÇÀÇ ÅëÇÕÀ¸·Î Á¢±Ù¼º°ú º¸±ÞÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :
À¯¸ÁÇÑ ¼ºÀå¼¼¿¡µµ ºÒ±¸Çϰí, µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀº ÷´Ü Áø´Ü ±â¼ú¿¡ µû¸¥ ³ôÀº ºñ¿ë°ú Àü¹® Áö½ÄÀÇ Çʿ伺À̶ó´Â °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ƯÈ÷ ¼Ò±Ô¸ð µ¿¹°º´¿øÀÇ °æ¿ì, ºÐÀÚÁø´ÜÀ» µµÀÔÇÏ´Â µ¥ ÇÊ¿äÇÑ Ãʱâ ÅõÀÚºñ¿ëÀÌ Å« ºÎ´ãÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºÐÀÚÁø´Ü °Ë»çÀÇ Ç¥ÁØÈ ¹× ±ÔÁ¦¿¡ ´ëÇÑ ¿ì·Á·Î ÀÎÇØ µµÀÔ°ú ½Å·Ú¼º¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ´Â Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü, ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç, ¸íÈ®ÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ÇÊ¿äÇϸç, À̸¦ ÅëÇØ µ¿¹° ÀÇÇп¡¼ ºÐÀÚÁø´ÜÀÇ ±¤¹üÀ§ÇÑ ¼ö¿ë°ú È¿°ú¸¦ º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ :
µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀº ±â¼ú Çõ½Å°ú ÁøÈÇÏ´Â ¼öÀÇÇÐÀû ¿ä±¸·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ¼öÀÇÇп¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ »õ·Î¿î Áø´Ü ºÐ¼®¹ý ¹× Ç÷§Æû ½ÃÀå °³Ã´Àº ½ÃÀå È®´ëÀÇ »õ·Î¿î ±æÀ» ¿¾îÁÖ°í ÀÖ½À´Ï´Ù. Áúº´ÀÇ Á¶±â ¹ß°ß ¹× ¿¹¹æ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¹Ý·Áµ¿¹°ÀÇ Àΰ£È Ãß¼¼´Â ÷´Ü ºÐÀÚÁø´ÜÀÇ Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϱâ À§Çؼ´Â Àü·«Àû ÆÄÆ®³Ê½Ê, R&D ÅõÀÚ, ÅëÇÕ Áø´Ü ¼Ö·ç¼Ç µµÀÔÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·é ÁÖ¿ä Áú¹®
¼¼°è µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
µ¿¹°¿ë ºÐÀÚÁø´ÜÀÇ Ã¤ÅÃÀ» ÁÖµµÇÏ´Â ¿ëµµ¿Í Áö¿ªÀº?
±â¼ú ¹ßÀüÀº ¼öÀÇÇÐ ºÐÀÚÁø´Ü ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô ÀçÆíÇϰí Àִ°¡?
µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¾îµð¿¡ ÀÖÀ¸¸ç, °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
¼¼°è µ¿¹°¿ë ºÐÀÚÁø´Ü ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú Àü¸ÁÀº?
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ºÐ·ù
½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
Æ÷ÇÔ »çÇס¤Á¦¿Ü »çÇ×
Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
½ÃÀåÀÇ Çõ½Å/°³¹ß µ¿Çâ
Á¦4Àå ÁÖ¿ä ¼º°ø ¿äÀÎ
ÁÖ¿ä ÇÁ·Î¸ð¼Ç Àü·« : Á¦Á¶¾÷üº°
ÁÖ¿ä ±ÔÁ¦
PESTEL ºÐ¼®
PorterÀÇ »ê¾÷ ºÐ¼®
Á¦Ç° ¹ß¸Å Ȱµ¿
Á¦Ç° äÅÃ/»ç¿ë »óȲ ºÐ¼®
Á¦Ç° USP/Ư¡
»ý»ê ºÐ¼® : Áö¿ªº°
ȯºÒ ½Ã³ª¸®¿À
°Å·¡ ºÐ¼®
¹ë·ùüÀÎ ºÐ¼®
Á¦5Àå ½ÃÀå ¹è°æ
°Å½Ã°æÁ¦ ¿äÀÎ
¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
½ÃÀå ¿ªÇÐ
Á¦6Àå COVID-19 À§±â ºÐ¼®
COVID-19¿Í ¿µÇ⠺м®
Á¦Ç°º°
Áúȯº°
À¯Çüº°
ÃÖÁ¾»ç¿ëÀÚº°
±¹°¡º°
2024³â ½ÃÀå ½Ã³ª¸®¿À
Á¦7Àå ¼¼°è ½ÃÀå ¼ö¿ä(±Ý¾× ¶Ç´Â ±Ô¸ð, ¹é¸¸ ´Þ·¯) ºÐ¼®
°ú°Å ½ÃÀå ±Ý¾×(¹é¸¸ ´Þ·¯) ºÐ¼®, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø : ½ÃÀå ºÐ·ùº°, 2024-2033³â
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Àý´ë¾× ±âȸ ºÐ¼®
Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼® : Á¦Ç°º°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : Á¦Ç°º°, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°, 2024-2033³â
PCR ŰƮ
INAAT ŰƮ
¸¶ÀÌÅ©·Î¾î·¹ÀÌ Å°Æ®
DNA ½ÃÄö½Ì ŰƮ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç°º°
Á¦9Àå ¼¼°è ½ÃÀå ºÐ¼® : Áúȯº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : Áúȯº°, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø : Áúȯº°, 2024-2033³â
Anaplasma spp.
Ehrlichia spp.
´ºÄ³½½º´
ÀÎÇ÷翣ÀÚ
µÅÁö»ý½Ä±âÈ£Èí±âÁõÈıº(PRRS)
±âŸ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áúȯº°
Á¦10Àå ¼¼°è ½ÃÀå ºÐ¼® : À¯Çüº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : À¯Çüº°, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø : À¯Çüº°, 2024-2033³â
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : À¯Çüº°
Á¦11Àå ¼¼°è ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2024-2033³â
µ¿¹°º´¿ø
ÀÓ»ó °Ë»ç½Ç
¼öÀÇÇÐ ¿¬±¸±â°ü
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
Á¦12Àå ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : Áö¿ªº°, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® ¿¹Ãø : Áö¿ªº°, 2024-2033³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ
¿À¼¼¾Æ´Ï¾Æ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ªº°
Á¦13Àå ºÏ¹Ì ½ÃÀå ºÐ¼®
Á¦14Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®
Á¦15Àå À¯·´ ½ÃÀå ºÐ¼®
Á¦16Àå µ¿¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®
Á¦17Àå ³²¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®
Á¦18Àå ¿À¼¼¾Æ´Ï¾Æ ½ÃÀå ºÐ¼®
Á¦19Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA) ½ÃÀå ºÐ¼®
Á¦20Àå ½ÃÀå ±¸Á¶ ºÐ¼®
½ÃÀå ºÐ¼® : ±â¾÷ °èÃþº°
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀå ÀÔÁö ºÐ¼®
Á¦21Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å·
°æÀï »ó¼¼ Á¤º¸
bioMerieux SA
IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
Qiagen NV
Neogen Corporation
ID. Vet
INDICAL BIOSCIENCE GmbH
Veterinary Molecular Diagnostics, Inc.
Á¦22Àå »ç¿ëµÇ´Â ÀüÁ¦ Á¶°Ç°ú µÎÀÚ¾î
Á¦23Àå Á¶»ç ¹æ¹ý
KSA
Persistence Market Research has recently published an extensive report on the global Veterinary Molecular Diagnostics market, providing a thorough analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report delivers a comprehensive understanding of the market landscape, helping stakeholders make informed decisions.
Key Insights:
Veterinary Molecular Diagnostics Market Size (2024E): USD 214.7 Mn
Projected Market Value (2033F): USD 437.7 Mn
Global Market Growth Rate (CAGR 2024 to 2033): 8.2%
Veterinary Molecular Diagnostics Market - Report Scope:
The Veterinary Molecular Diagnostics market encompasses a range of advanced diagnostic technologies used for the precise detection and analysis of diseases in animals. These technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS), and other molecular methods that offer high sensitivity and specificity for diagnosing various veterinary conditions. Molecular diagnostics are crucial for identifying pathogens, genetic disorders, and other health issues in pets and livestock, leading to improved disease management and treatment outcomes. The market is driven by advancements in molecular biology, the increasing prevalence of zoonotic diseases, and the growing demand for rapid and accurate diagnostic solutions.
Market Growth Drivers:
The global Veterinary Molecular Diagnostics market is propelled by several key factors, including the rising incidence of infectious diseases in animals, increased pet ownership, and growing awareness about animal health. Molecular diagnostics offer precise and timely results, which are essential for effective disease management and prevention. The expansion of veterinary healthcare infrastructure and advancements in diagnostic technologies, such as the development of portable and user-friendly diagnostic devices, are also contributing to the market's growth. Additionally, the integration of molecular diagnostics with telemedicine and digital health solutions is enhancing their accessibility and adoption.
Market Restraints:
Despite its promising growth, the Veterinary Molecular Diagnostics market faces challenges such as high costs associated with advanced diagnostic technologies and the need for specialized expertise. The initial investment required for implementing molecular diagnostics in veterinary practices can be significant, especially for smaller clinics. Additionally, there are concerns related to the standardization and regulation of molecular diagnostic tests, which can impact their adoption and reliability. Addressing these challenges requires ongoing advancements in technology, cost-effective solutions, and clear regulatory frameworks to ensure the broad acceptance and effectiveness of molecular diagnostics in veterinary care.
Market Opportunities:
The Veterinary Molecular Diagnostics market presents significant growth opportunities driven by technological innovations and evolving veterinary needs. The development of novel diagnostic assays and platforms, along with the increasing focus on personalized veterinary care, is opening new avenues for market expansion. The rising demand for early disease detection and prevention, coupled with the growing trend of pet humanization, is expected to drive the adoption of advanced molecular diagnostics. Strategic partnerships, investments in R&D, and the introduction of integrated diagnostic solutions will be crucial for companies looking to capitalize on these opportunities and drive market growth.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the Veterinary Molecular Diagnostics market globally?
Which applications and regions are leading the adoption of Veterinary Molecular Diagnostics?
How are technological advancements reshaping the competitive landscape of the Veterinary Molecular Diagnostics market?
Who are the key players in the Veterinary Molecular Diagnostics market, and what strategies are they employing to stay competitive?
What are the emerging trends and future prospects in the global Veterinary Molecular Diagnostics market?
Competitive Intelligence and Business Strategy:
Leading companies in the global Veterinary Molecular Diagnostics market, such as IDEXX Laboratories, Neogen Corporation, and Zoetis, are focusing on innovation, technological advancements, and strategic collaborations to maintain a competitive edge. These companies are investing heavily in R&D to develop cutting-edge diagnostic solutions that improve animal health and streamline veterinary practices. Partnerships with research institutions, technology providers, and healthcare organizations are essential for expanding market reach and enhancing diagnostic capabilities. Emphasizing accuracy, cost-effectiveness, and comprehensive diagnostic solutions are key strategies for sustaining leadership in the rapidly evolving Veterinary Molecular Diagnostics market.
Key Companies Profiled:
bioMerieux SA
IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
Qiagen N.V.
Neogen Corporation
ID. Vet
INDICAL BIOSCIENCE GmbH
Veterinary Molecular Diagnostics, Inc.
Key Segments Covered in Veterinary molecular diagnostics Industry Research
Product
PCR Kits
INAAT Kits
Microarray Kits
DNA Sequencing Kits
Disease
Anaplasma spp.
Ehrlichia spp.
New Castle Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Species
Livestock Animals
Companion Animals
End User
Veterinary Hospitals
Clinical Laboratories
Veterinary Research Institutes
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends
4. Key Success Factors
4.1. Key Promotional Strategies, by Manufacturers
4.2. Key Regulations
4.3. PESTEL Analysis
4.4. Porter's Analysis
4.5. Product Launch Activities
4.6. Product Adoption/Usage Analysis
4.7. Product USPs/ Features
4.8. Production Analysis by Region
4.9. Reimbursement Scenario
4.10. Trade Analysis
4.11. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Veterinary Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increasing Strategic Collaborations Among Key Players
5.2.2. Rise in Awareness About Diseases in Animals Worldwide
5.2.3. High Adoption of Molecular Diagnostic Kits for Veterinary Diseases
5.2.4. Higher Prevalence of Chronic & Infectious Diseases in Animals
5.2.5. Advancements in Molecular Technology
5.2.6. Growing Acceptance of Advanced Molecular Diagnostic Techniques
5.2.7. Ease in FDA Clearance for Veterinary Products
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Disease
6.1.3. By Species
6.1.4. By End User
6.1.5. By Country
6.2. 2024 Market Scenario
7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2024-2033
8.3.1. PCR Kits
8.3.1.1. RT-PCR Kits
8.3.1.2. RAPD-PCR Kits
8.3.2. INAAT Kits
8.3.3. Microarray Kits
8.3.4. DNA Sequencing Kits
8.4. Market Attractiveness Analysis by Product
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
9.3.1. Anaplasma spp.
9.3.2. Ehrlichia spp.
9.3.3. New Castle Disease
9.3.4. Influenza
9.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
9.3.6. Others
9.4. Market Attractiveness Analysis by Disease
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Species
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Species, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Species, 2024-2033
10.3.1. Livestock Animals
10.3.1.1. Porcine
10.3.1.2. Poultry
10.3.1.3. Bovine/Cattle
10.3.1.4. Aquatic
10.3.1.5. Ovine
10.3.2. Companion Animals
10.3.2.1. Canine
10.3.2.2. Feline
10.3.2.3. Avian
10.4. Market Attractiveness Analysis by Species
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
11.3.1. Veterinary Hospitals
11.3.2. Clinical Laboratories
11.3.3. Veterinary Research Institutes
11.4. Market Attractiveness Analysis by End User
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis Forecast by Region, 2024-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis by Region
13. North America Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Disease
13.3.4. By Species
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Disease
13.4.4. By Species
13.4.5. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. U.S. Market
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Disease
13.8.1.2.3. By Species
13.8.1.2.4. By End User
13.8.2. Canada Market
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Disease
13.8.2.2.3. By Species
13.8.2.2.4. By End User
14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Mexico
14.3.1.2. Brazil
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Disease
14.3.4. By Species
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Disease
14.4.4. By Species
14.4.5. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Mexico Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Disease
14.8.1.2.3. By Species
14.8.1.2.4. By End User
14.8.2. Brazil Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Disease
14.8.2.2.3. By Species
14.8.2.2.4. By End User
14.8.3. Argentina Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Disease
14.8.3.2.3. By Species
14.8.3.2.4. By End User
15. Europe Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Disease
15.3.4. By Species
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Disease
15.4.4. By Species
15.4.5. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Germany Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Disease
15.8.1.2.3. By Species
15.8.1.2.4. By End User
15.8.2. Italy Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Disease
15.8.2.2.3. By Species
15.8.2.2.4. By End User
15.8.3. France Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Disease
15.8.3.2.3. By Species
15.8.3.2.4. By End User
15.8.4. U.K. Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Disease
15.8.4.2.3. By Species
15.8.4.2.4. By End User
15.8.5. Spain Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Product
15.8.5.2.2. By Disease
15.8.5.2.3. By Species
15.8.5.2.4. By End User
15.8.6. BENELUX Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Product
15.8.6.2.2. By Disease
15.8.6.2.3. By Species
15.8.6.2.4. By End User
15.8.7. Russia Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Product
15.8.7.2.2. By Disease
15.8.7.2.3. By Species
15.8.7.2.4. By End User
16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Disease
16.3.4. By Species
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Disease
16.4.4. By Species
16.4.5. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. China Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Disease
16.8.1.2.3. By Species
16.8.1.2.4. By End User
16.8.2. Japan Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Disease
16.8.2.2.3. By Species
16.8.2.2.4. By End User
16.8.3. South Korea Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Disease
16.8.3.2.3. By Species
16.8.3.2.4. By End User
17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Disease
17.3.4. By Species
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Disease
17.4.4. By Species
17.4.5. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. India Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Disease
17.8.1.2.3. By Species
17.8.1.2.4. By End User
17.8.2. Indonesia Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Disease
17.8.2.2.3. By Species
17.8.2.2.4. By End User
17.8.3. Malaysia Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Disease
17.8.3.2.3. By Species
17.8.3.2.4. By End User
17.8.4. Thailand Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Disease
17.8.4.2.3. By Species
17.8.4.2.4. By End User
18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Disease
18.3.4. By Species
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Disease
18.4.4. By Species
18.4.5. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. Australia Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Disease
18.8.1.2.3. By Species
18.8.1.2.4. By End User
18.8.2. New Zealand Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Disease
18.8.2.2.3. By Species
18.8.2.2.4. By End User
19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkiye
19.3.1.3. North Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Disease
19.3.4. By Species
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Disease
19.4.4. By Species
19.4.5. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Disease
19.8.1.2.3. By Species
19.8.1.2.4. By End User
19.8.2. Turkiye Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Disease
19.8.2.2.3. By Species
19.8.2.2.4. By End User
19.8.3. South Africa Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Disease
19.8.3.2.3. By Species
19.8.3.2.4. By End User
19.8.4. North Africa Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Disease
19.8.4.2.3. By Species
19.8.4.2.4. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. bioMerieux SA
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Key Financials
21.3.1.5. SWOT Analysis
21.3.1.6. Key Developments
21.3.1.7. Strategy Overview
21.3.1.7.1. Marketing Strategy
21.3.1.7.2. Product Strategy
21.3.1.7.3. Channel Strategy
21.3.2. IDEXX Laboratories, Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Key Financials
21.3.2.5. SWOT Analysis
21.3.2.6. Key Developments
21.3.2.7. Strategy Overview
21.3.2.7.1. Marketing Strategy
21.3.2.7.2. Product Strategy
21.3.2.7.3. Channel Strategy
21.3.3. Thermo Fisher Scientific Inc.
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Key Financials
21.3.3.5. SWOT Analysis
21.3.3.6. Key Developments
21.3.3.7. Strategy Overview
21.3.3.7.1. Marketing Strategy
21.3.3.7.2. Product Strategy
21.3.3.7.3. Channel Strategy
21.3.4. Qiagen N.V.
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Key Financials
21.3.4.5. SWOT Analysis
21.3.4.6. Key Developments
21.3.4.7. Strategy Overview
21.3.4.7.1. Marketing Strategy
21.3.4.7.2. Product Strategy
21.3.4.7.3. Channel Strategy
21.3.5. Neogen Corporation
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Key Financials
21.3.5.5. SWOT Analysis
21.3.5.6. Key Developments
21.3.5.7. Strategy Overview
21.3.5.7.1. Marketing Strategy
21.3.5.7.2. Product Strategy
21.3.5.7.3. Channel Strategy
21.3.6. ID. Vet
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Key Financials
21.3.6.5. SWOT Analysis
21.3.6.6. Key Developments
21.3.6.7. Strategy Overview
21.3.6.7.1. Marketing Strategy
21.3.6.7.2. Product Strategy
21.3.6.7.3. Channel Strategy
21.3.7. INDICAL BIOSCIENCE GmbH
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Key Financials
21.3.7.5. SWOT Analysis
21.3.7.6. Key Developments
21.3.7.7. Strategy Overview
21.3.7.7.1. Marketing Strategy
21.3.7.7.2. Product Strategy
21.3.7.7.3. Channel Strategy
21.3.8. Veterinary Molecular Diagnostics, Inc.
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Key Financials
21.3.8.5. SWOT Analysis
21.3.8.6. Key Developments
21.3.8.7. Strategy Overview
21.3.8.7.1. Marketing Strategy
21.3.8.7.2. Product Strategy
21.3.8.7.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology